All attending UK organisations

UK companies attending UK @BIO-Europe 2018 as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK: UK stand, booth #39
Abzena, Cello Health, Cobra Biologics, Evaluate, Fujifilm Diosynth, GlobalData, Life Sciences in the Northern Powerhouse, NIHR, PharmaIntelligence, SGS Vitrology, SQN Clinical, Symbiosis.

Life Sciences in the Northern Powerhouse:
Alderley Park, Aptus Clinical, Bionow, Invest Liverpool, Peak Proteins, The Northern Health Science Alliance (NHSA)

UK stand (booth 39):
Alacrita Holdings, Arcinova, BioIndustry Association (BIA), Centre of Excellence in Infectious Diseases Research, Clinical Network Services (UK), Crystec, GTN, High Force Research, IAG, Inivata, Intract Pharma, Karma Oncology, LSX, Medherant, MediWales, Nanna Therapeutics, National Institute for Health Research (NIHR), OBN, One Nucleus, OxStem, Scottish Development International, Therakind.

Other UK companies associated with the delegation*:
ALSA Holdings, AMR Centre, Biorelate, Cello Health Consulting, CIMYM BioSciences, Circassia Pharmaceuticals, Clinical Accelerator, COLLAGEN SOLUTIONS, Colliers International Property, Concept Life Sciences, Curileum Discovery, Cypralis, Diamond Biopharm, Enesi Pharma, ERA Consulting UK, e-therapeutics, Evotec AG, Exploristics, Fusion Antibodies, Global Regulatory Services, HC Pharma Consultancy, HungaroTrial, Illetrop, IN-PARt, Instinctif Partners, metaLinear, Mironid, N4 Pharma, Oppilotech, Precision for Medicine,  Oncology and Rare Disease, ProImmune, Quay Pharmaceuticals, Redx Pharma, Renovos Biologics, Sareum, SBA, scientist.com, Sekisui, Sygnature Discovery, SYNthesis Research, Tissue Solutions, UCB, VHsquared, Xenogesis.

UK Presenting companies:
Curileum Discovery, Cypralis, Exscientia, GTN, LIfT Biosciences, Lycotec, MiNA Therapeutics.

All attending UK companies:
Alacrita Holdings,  3M United Kingdom, 4D Pharma, AbbVie, Abcam, Abingworth,  Abzena, Aigenpulse,  Akari Therapeutics, Albumedix, Alderley Park,  Almac Discovery, Alpha Blue Ocean, AlphaBiomics, Alpharmaxim, ALSA HOLDINGS, AMO Pharma, AMR Centre,  Apex Healthcare Consulting,  Apitope Technology, Apollo Therapeutics, Aptus Clinical,  Arcinova, Arix Bioscience Holdings,  Arnold & Porter Kaye Scholer,  ARTIOS PHARMA,  Astellas Pharma Europe,  AstraZeneca, Atelix,  Athena Market Access Solutions,  AURUM Biosciences,  Autolus,  Avacta Life Sciences, Barrington James, Bayer UK, BenevolentAI, BG advisors, BioIndustry Association (BIA), BioPartner UK, Biopharma Group, Biorelate, Bioscience Pharma Partners, BiVictriX Therapeutics,  Boult Wade Tennant, Bridge Valley Ventures, Bristows,  Camena Bioscience,  Cancer Research UK, Celerion, Cell and Gene Therapy Catapult, Cello Health Consulting, Centauri Therapeutics, Centre of Excellence in Infectious Diseases Research, CIMYM Biosciences, Circassia Pharmaceuticals, Clarivate Analytics, Clinical Accelerator, Clinical Network Services (UK),  Clinigen Group, CN Bio Innovations,  Cobra Biologics, COLLAGEN SOLUTIONS, Colliers International Property, Concept Life Sciences, Confluence Tax, Consilient Health, Coulter Partners, Covance / Chiltern, Crescendo Biologics,  Crystec, Curileum Discovery,  Cypralis, DataArt Technologies UK,  David Harrison - Business Development Consultant, Dechert (Paris),  Decision Resources Group, Destiny Pharma, Diamond Pharma Services, Diurnal Group, DJS Antibodies, Drug Discovery Unit University of Dundee, e Therapeutics, EBD Academy,  EBD Group, Edinburgh Innovations,  Edison, Eisai Co,  Eli Lilly, Embera NeuroTherapeutics Inc, Enesi Pharma, Epidarex Capital Management,  ERA Consulting, ERT, Ethypharm, EUSA Pharma, Evaluate,  Evotec UK,  Expedeon, Exploristics, Exscientia,  Ferghana Partners, Fieldfisher,  FirstWord Publishing UK,  F-star Biotechnology,  FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, Galen,  GE Healthcare, Global Regulatory Services,  GlobalData, Gowling WLG (UK),  Greenhill, GTN,  HC Pharma Consultancy,  Health and Care Research Wales, Heptares Therapeutics,  High Force Research, Horizon Discovery, HungaroTrial, IAG, ideaPoint, IGEM Therapeutics,  Iksuda Therapeutics, Illetrop,  ImmuPharma, Inceptua GmbH, Informa, Informa/Scrip, Inivata, IN-PART, Instinctif Partners, Intract Pharma, IONTAS, IP Group, IpI media world, IQVIA, IQVIA - Global Market Insights,  Isogenica, Johnson & Johnson Innovation, Karma Oncology,  Karus Therapeutics, Kymab, Kyowa Kirin International,  lamellar biomedical,  Latham & Watkins, LifeArc, Lifescience Industry, LIfT BioSciences, LightOx,  Liverpool Vision, Locust Walk, Lonza Pharma & Biotech, LSX,  Lycotec, Macrophage Pharma,  Mallinckrodt Pharmaceuticals, Mawdsleys, Medherant, Medicilon UK/EU Office - Link China Pharma, MEDICXI, MedImmune, Medius Associates, MedPharm, Merck KGaA, Mereo BioPharma, metaLinear,  Metrion Biosciences, Microbiotica, Midatech Pharma, Mills & Reeve,  MiNA Therapeutics, Mironid, Mission Therapeutics, Mitra Biotech, Mitsubishi Tanabe Pharma, MSD, Mundipharma International,  Mundipharma Research, N4 Pharma, Nanna Therapeutics, NANOGAP Therapeutics, NANOGENICS,  Nanomerics, National Institute for Health Research, Nature Research, NDA Regulatory Service GmbH, Neem Biotech,  Newcastle University / NIHR Innovation Observatory, Next Health, Norgine Ventures,  Northern Powerhouse (Bionow),  OBN UK,  One Nucleus, Ono Pharma, Oppilotech,  Orbit Discovery, Ossianix, Otsuka Pharmaceutical Company, Oval Medical Technologies, Oxford BioMedica, OxStem,  PAREXEL International, Patheon part of Thermo Fisher Scientific, Peak Proteins, PeproTech, Pfizer, Pharmalicensing, PharmaVentures, Piramal Pharma Solutions, Planet Pharma Staffing,  Plexus Ventures, PPD, Precision for Medicine Oncology and Rare Disease,  Premier Research,  ProAxsis,  Procarta Biosystems, ProImmune,  Prokarium, PsiOxus Therapeutics,  Q2 Solutions, Quay Pharmaceuticals,  Queen's University Belfast, Quotient Sciences, Random42 Scientific Communication, RBW Consulting, RedX Pharma, Renovos Biologics,  Rephine,  Results Healthcare, ReViral,  Richmond Pharmacology, RiverFort Global Capital,  Rosemont Pharmaceuticals,  Samedan,  Sanofi, Sareum,  Sartorius Stedim BioOutsource,  SBA,  Scancell,  scientistcom, Scius Communications, Scottish Development International, SEC Recruitment, Sekisui, SGS Vitrology, Sidley Austin,  Silence Therapeutics, Silicon Valley Bank, Simbec-Orion, Simcere Pharmaceutical Group, SiSaf,  Skills Alliance Pharma,  SLA Pharma, SmartAnalyst Inc, Solid Form Solutions - Avista Pharma, Springer Nature, SQN Clinical, Storm Therapeutics,  Summit Therapeutics, Sygnature Discovery, Symbiosis Pharmaceutical Services, Synairgen Research,  Syneos Health, Synpromics, SYNthesis Research, Takeda, Taylor Wessing,  TCRS, Teijin Pharma,  Teva Pharmaceuticals, The Fulford Group, The Northern Health Science Alliance  (NHSA), The RSA Group, The Sage Group, Theolytics,  Therakind,  Tissue Solutions,  Tolley Health Economics,  Torreya, Treehill Partners, Treos Bio Zrt, Ubiquigent,  UCB Pharma, Ulster University, University of Bristol, University of Glasgow Stratified Medicine, Utility Therapeutics,  VHsquared,  Viramal,  VirdisGroup, Voisin Consulting Life Sciences (VCLS), Vygoris,  West Pharmaceutical Services, Wildwood Ventures / Current Partnering, World Child Cancer, WuXi AppTec, WuXi Biologics, Xenogesis, Ximbio. (299)

Join them here!